The House easily approved a sweeping biomedical bill Wednesday that would help drug and medical device companies win swifter government approval of their products, boost disease research and drug-abuse spending and revamp federal mental health programs.
The compromise, which envisions spending $6.3 billion over the next decade, was condemned by consumer groups and some Democrats as a present to drugmakers that promised only paltry spending increases for underfunded federal programs.
But their objections were overwhelmed by an alliance among Republicans, many Democrats and the White House for a 996-page measure that bore wins for both parties. The Senate’s expected final approval next week would mark an uncommon episode of cooperation between the GOP-run 114th Congress – which plans to adjourn next week – and President Barack Obama in their dwindling days in office.
Click here to Read the full article : House Passes Controversial Medical Funding ‘Cures’ Bill
Share this entry
- Jaimie Krzynski, BSN/RN, is Appointed to the American Health Council’s Board of Nurses July 20, 2017
- American Health Council Names Diana Getsy-Holiday, RN, CD, CAP, ChT, BHT, ICADC to Nursing Board July 20, 2017
- The American Health Council Names Paul Aoun, DO/PhD, to Board of Physicians July 19, 2017
- The AHC Names Ferdinando Mirarchi, DO/FAAEM/FACEP, to its Board of Physicians July 18, 2017
- American Health Council Appoints Jonel Kinser, BSN/RN, to its Board of Nurses July 18, 2017
- American Health Council Names Husam Issa, MD, With Admission to Physician Board July 17, 2017